Zobrazeno 1 - 10
of 162
pro vyhledávání: '"G. Follea"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Transfusion Clinique et Biologique. 16:93-100
Contexte. - L'amelioration continue de l'efficience a l'EFS et les nouvelles attentes des clients et des salaries impliquent des efforts constants d'amelioration organisationnelle. Methodes. - La methode Lean, du mot anglais signifiant « mince », v
Autor:
P. Millson, M. Giroux, James P. AuBuchon, N. Barrowman, W. Kim, G. Follea, J. Kreppner, Susan M. King, R. Z. Shaul, B. Squires
Publikováno v:
Vox Sanguinis. 83:188-193
1 The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada 2 Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA 3 Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada 4 Etablissm
Publikováno v:
Transfusion Clinique et Biologique. 8:403-409
Resume Le remplacement en 1995 du Veneral Disease Research Laboratory (VDRL) par le Treponema Pallidum Hemagglutination Assay ( TPHA) pour le depistage de la syphilis sur les dons de sang a la Martinique a ete suivi d’une forte augmentation du nomb
Autor:
M.-J. Pinson, F. Bonneville, A. Cesbron-Gautier, P. Herfray, Jean-Denis Bignon, P. Herry, M.L. Cheneau, G. Follea, Katia Gagne
Publikováno v:
Tissue Antigens. 60:268-270
This communication reports the identification of a new HLA-DRB1*03 allele identified in three members of a Caucasian French family. This new allele has been officially named HLA-DRB1*0321 by the World Health Organization Nomenclature Committee. The c
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 16(2)
Continuous improvement of efficiency as well as new expectations from customers (quality and safety of blood products) and employees (working conditions) imply constant efforts in Blood Transfusion Establishments (BTE) to improve work organisations.T
Autor:
M. Masse, M. Angué, G. Andreu, F Beaujean, J.P. Calot, ML Bidet, C. Cotte, G Follea, C Babault, D Boudart
Publikováno v:
Transfusion. 31:792-797
To evaluate accurately the current performance of filtration, the French Produits Sanguins Labiles study group, composed of 21 transfusion teams, conducted a large-scale 6-month study involving over 1400 filtrations and 3000 controls. Some 745 standa
Autor:
A. Faradji, A. Bohbot, M. Schmitt-Goguel, S. Dumont, A. Eischen, M.L. Wiesel, A. Stierle, G. Follea, M. Eber, J.P. Bergerat, J. Bartholeyns, P. Poindron, J.P. Witz, H. Frost, F. Oberling
Publikováno v:
The International Journal of Artificial Organs. 14:304-312
Human blood monocytes (Mo) and monocyte-derived macrophages (MØ) are known to be potent antitumor cytotoxic effector cells through activation with recombinant human interferon gamma (rIFN-y), bacterial muramyldipeptide or the synthetic derivative mu
Autor:
A. Faradji, A. Bohbot, J. Damonte, J.P. Arnaud, M. Eber, D. Laustriat, J. Goetz, M.L. Wiesel, G. Follea, Y. Piemont, J.P. Bergerat, J.P. Cazenave, M. Adloff, F. Oberling
Publikováno v:
The International Journal of Artificial Organs. 14:109-115
To evaluate the safety of on-line plasma perfusion over protein-A sepharose and the therapeutic advantage of combining plasma perfusion (PP) over protein-A sepharose with 5-fluorouracil (5-FU) chemotherapy in patients with metastatic colorectal carci
Autor:
G. Follea
Publikováno v:
Transfusion Clinique et Biologique. 22:193
Background Patient blood management (PBM) is a multi-disciplinary evidence based approach to the care of patients who might need transfusion. In 2014, the European Blood Alliance (EBA) facilitated the collaboration of 7 University Hospitals in Europe